Johnston John Joseph 4
4 · MAXCYTE, INC. · Filed Dec 30, 2024
Insider Transaction Report
Form 4
MAXCYTE, INC.MXCT
Johnston John Joseph
Director
Transactions
- Exercise/Conversion
Common Stock
2024-12-26$2.93/sh+3,000$8,796→ 144,950 total - Exercise/Conversion
Stock Option (right to buy)
2024-12-26−3,000→ 20,417 totalExercise: $2.93Exp: 2028-07-18→ Common Stock (3,000 underlying) - Sale
Common Stock
2024-12-26$4.01/sh−3,000$12,021→ 141,950 total
Footnotes (3)
- [F1]The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.
- [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.995 to $4.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]This option is fully vested and exercisable.